Thomas E. Steinbacher

766 total citations
30 papers, 469 citations indexed

About

Thomas E. Steinbacher is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Molecular Biology. According to data from OpenAlex, Thomas E. Steinbacher has authored 30 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 11 papers in Hematology and 6 papers in Molecular Biology. Recurrent topics in Thomas E. Steinbacher's work include Blood Coagulation and Thrombosis Mechanisms (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Inflammatory mediators and NSAID effects (6 papers). Thomas E. Steinbacher is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Inflammatory mediators and NSAID effects (6 papers). Thomas E. Steinbacher collaborates with scholars based in United States, Germany and Sweden. Thomas E. Steinbacher's co-authors include William A. Schumacher, Martin L. Ogletree, Christopher L. Heran, Jeffrey S. Bostwick, Karen S. Hartl, Stephen K. Durham, Pancras C. Wong, J R Megill, Michael J. Antonaccio and John R. Megill and has published in prestigious journals such as Blood, Journal of Applied Physiology and Journal of Medicinal Chemistry.

In The Last Decade

Thomas E. Steinbacher

29 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas E. Steinbacher United States	15	184	180	108	100	69	30	469
Christopher L. Heran United States	14	122 0.7×	162 0.9×	56 0.5×	121 1.2×	57 0.8×	22	503
Stan Kurowski United States	8	129 0.7×	175 1.0×	47 0.4×	71 0.7×	56 0.8×	14	362
Viveca Nerme Sweden	15	210 1.1×	113 0.6×	56 0.5×	199 2.0×	30 0.4×	21	488
Tsukasa Ishihara Japan	15	93 0.5×	242 1.3×	49 0.5×	164 1.6×	36 0.5×	45	600
M A Orchard United Kingdom	13	125 0.7×	84 0.5×	31 0.3×	205 2.0×	25 0.4×	36	606
K L Fong United States	13	198 1.1×	38 0.2×	53 0.5×	116 1.2×	21 0.3×	33	496
H Weisenberger Germany	13	78 0.4×	214 1.2×	14 0.1×	82 0.8×	50 0.7×	21	463
Taketoshi Ogawa Japan	14	166 0.9×	541 3.0×	71 0.7×	98 1.0×	147 2.1×	30	827
Denis Delebassée France	7	136 0.7×	281 1.6×	21 0.2×	42 0.4×	88 1.3×	9	457
Martina H. Lundberg United Kingdom	10	70 0.4×	159 0.9×	12 0.1×	79 0.8×	45 0.7×	13	495

Countries citing papers authored by Thomas E. Steinbacher

Since Specialization

Citations

This map shows the geographic impact of Thomas E. Steinbacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Steinbacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Steinbacher more than expected).

Fields of papers citing papers by Thomas E. Steinbacher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Steinbacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Steinbacher. The network helps show where Thomas E. Steinbacher may publish in the future.

Co-authorship network of co-authors of Thomas E. Steinbacher

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Steinbacher. A scholar is included among the top collaborators of Thomas E. Steinbacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Steinbacher. Thomas E. Steinbacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Hongbin, Hongtao Pan, G. Janeschitz, et al.. (2025). The conceptual design of transporter & secondary containment structure of maintenance cask for CFETR and EU-DEMO blanket. Fusion Engineering and Design. 215. 114977–114977.

Bachmann, C., et al.. (2024). Conceptual design of DEMO breeding blanket in-vessel toroidal transporter. Fusion Engineering and Design. 202. 114389–114389. 1 indexed citations

Mozzillo, Rocco, C. Bachmann, Pierluigi Fanelli, G. Janeschitz, & Thomas E. Steinbacher. (2023). Structural assessment of the gripper interlock of the DEMO breeding blanket transporter. Heliyon. 9(8). e18926–e18926. 3 indexed citations

Schumacher, William A., et al.. (2010). Effect of the Direct Factor Xa Inhibitor Apixaban in Rat Models of Thrombosis and Hemostasis. Journal of Cardiovascular Pharmacology. 55(6). 609–616. 27 indexed citations

Shi, Yan, Jing Zhang, Mengxiao Shi, et al.. (2009). Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(15). 4034–4041. 13 indexed citations

Shi, Yan, Chi Li, Stephen P. O’Connor, et al.. (2009). Aroylguanidine-based factor Xa inhibitors: The discovery of BMS-344577. Bioorganic & Medicinal Chemistry Letters. 19(24). 6882–6889. 19 indexed citations

Schumacher, William A., Jeffrey S. Bostwick, Martin L. Ogletree, et al.. (2007). Biomarker Optimization to Track the Antithrombotic and Hemostatic Effects of Clopidogrel in Rats. Journal of Pharmacology and Experimental Therapeutics. 322(1). 369–377. 29 indexed citations

Tamura, James, Jeffrey S. Bostwick, Thomas E. Steinbacher, et al.. (2007). Is exogenous tissue plasminogen activator necessary for antithrombotic efficacy of an inhibitor of thrombin activatable fibrinolysis inhibitor (TAFI) in rats?. Thrombosis Research. 120(4). 549–558. 11 indexed citations

Wang, Xinkang, Mei-Yin Hsu, Thomas E. Steinbacher, Thomas M. Monticello, & William A. Schumacher. (2006). Quantification of platelet composition in experimental venous thrombosis by real-time polymerase chain reaction. Thrombosis Research. 119(5). 593–600. 26 indexed citations

10.

Schumacher, William A., Thomas E. Steinbacher, John R. Megill, & Stephen K. Durham. (1996). A ferret model of electrical-induction of arterial thrombosis that is sensitive to aspirin. Journal of Pharmacological and Toxicological Methods. 35(1). 3–10. 18 indexed citations

11.

Schumacher, William A., Christopher L. Heran, & Thomas E. Steinbacher. (1996). Low-Molecular-Weight Heparin (Fragmin) and Thrombin Active-Site Inhibitor (Argatroban) Compared in Experimental Arterial and Venous Thrombosis and Bleeding Time. Journal of Cardiovascular Pharmacology. 28(1). 19–25. 30 indexed citations

12.

Schumacher, William A., Christopher L. Heran, & Thomas E. Steinbacher. (1996). Sensitivity of experimental venous and arterial thrombosis and bleeding to ancrod-induced defibrinogenation. Thrombosis Research. 81(2). 187–194. 3 indexed citations

13.

Schumacher, William A., et al.. (1993). Superior Activity of a Thromboxane Receptor Antagonist as Compared with Aspirin in Rat Models of Arterial and Venous Thrombosis. Journal of Cardiovascular Pharmacology. 22(4). 526–533. 30 indexed citations

14.

Schumacher, William A., Thomas E. Steinbacher, Christopher L. Heran, J R Megill, & Stephen K. Durham. (1993). Effects of Antithrombotic Drugs in a Rat Model of Aspirin-Insensitive Arterial Thrombosis. Thrombosis and Haemostasis. 69(5). 509–514. 32 indexed citations

15.

Schumacher, William A., Thomas E. Steinbacher, J R Megill, et al.. (1992). Thrombin inhibition compared with other antithrombotic drugs in rats. Thrombosis Research. 68(2). 157–166. 10 indexed citations

16.

Schumacher, William A., et al.. (1992). Antiplatelet activity of the long-acting thromboxane receptor antagonist BMS 180,291 in monkeys. Prostaglandins. 44(5). 389–397. 14 indexed citations

17.

Harris, Don N., Inge M. Michel, Harold Goldenberg, et al.. (1992). Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.. Journal of Pharmacology and Experimental Therapeutics. 261(1). 131–137. 3 indexed citations

18.

Schumacher, William A., et al.. (1990). Role of thromboxane receptor activation in the bronchospastic response to endothelin. Prostaglandins. 40(1). 71–79. 22 indexed citations

19.

Schumacher, William A., et al.. (1989). Role of thromboxane receptors in Forssman shock in guinea pigs. Journal of Applied Physiology. 67(1). 44–51. 2 indexed citations

20.

Vollmer, Regis R., et al.. (1981). Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.. Journal of Pharmacology and Experimental Therapeutics. 216(2). 225–231. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact